Pfizer interested in over-the-counter Lipitor: report

NEW YORK (Reuters) – Pfizer Inc is interested in selling a non-prescription version of its Lipitor cholesterol drug after it loses U.S. patent protection, but would likely face a battle with regulators because of safety concerns, the Wall Street Journal reported on Wednesday.




View full post on Reuters: Business News

Share and Enjoy:
  • Print this article!
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks

Leave a Reply


Powered by Yahoo! Answers